BlackRock Investment Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.8M | Sell |
435,720
-2,154
| -0.5% | -$8.9K | ﹤0.01% | 2283 |
|
|
2016
Q3 | $3.55M | Buy |
437,874
+674
| +0.2% | +$5.46K | ﹤0.01% | 1727 |
|
|
2016
Q2 | $3.41M | Buy |
437,200
+33,620
| +8% | +$262K | ﹤0.01% | 1709 |
|
|
2016
Q1 | $3.12M | Buy |
403,580
+8,307
| +2% | +$64.1K | ﹤0.01% | 1694 |
|
|
2015
Q4 | $4.27M | Buy |
395,273
+1,482
| +0.4% | +$16K | 0.01% | 1493 |
|
|
2015
Q3 | $2.72M | Sell |
393,791
-5,431
| -1% | -$37.5K | ﹤0.01% | 1831 |
|
|
2015
Q2 | $3.54M | Buy |
399,222
+28,773
| +8% | +$255K | ﹤0.01% | 1770 |
|
|
2015
Q1 | $3.65M | Buy |
370,449
+60,311
| +19% | +$595K | ﹤0.01% | 1605 |
|
|
2014
Q4 | $3.8M | Sell |
310,138
-3,458
| -1% | -$42.4K | 0.01% | 1577 |
|
|
2014
Q3 | $3.13M | Buy |
313,596
+3,321
| +1% | +$33.1K | ﹤0.01% | 1677 |
|
|
2014
Q2 | $2.35M | Buy |
310,275
+40,941
| +15% | +$310K | ﹤0.01% | 1946 |
|
|
2014
Q1 | $886K | Buy |
269,334
+149
| +0.1% | +$490 | ﹤0.01% | 2578 |
|
|
2013
Q4 | $893K | Sell |
269,185
-4,730
| -2% | -$15.7K | ﹤0.01% | 2570 |
|
|
2013
Q3 | $827K | Buy |
273,915
+19,879
| +8% | +$60K | ﹤0.01% | 2570 |
|
|
2013
Q2 | $2.08M | Buy |
+254,036
| New | +$2.08M | ﹤0.01% | 1822 |
|